Clinical trial
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia…
NCT00130923 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00130923 |
|---|---|
| Title | Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder |
| Official title | Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST) |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychotic Disorders, Substance Abuse, Alcohol Abuse |
| Intervention type | Drug |
| Interventions | Risperidone Long Acting, oral risperidone |
| Enrollment | 95 |
| Start date | Sep 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | Aug 16, 2005 |
| Last update posted | May 9, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: